SCAI continues to oppose proposed local Medicare coverage policies that would restrict patient access to invasive fractional flow reserve (FFR) tests. Palmetto (North Carolina, South Carolina, Virginia, West Virginia) finalized its policy without restrictions. We are awaiting a final coverage from Noridian (Alaska, Arizona, California, Guam, Hawaii, Idaho, Montana, Nevada, North Dakota, Northern Mariana Islands, Oregon, South Dakota, Utah, Washington, Wyoming). And in November 2020, SCAI filed comments with CGS (Kentucky & Ohio) and WPS (Iowa, Kansas, Missouri, Nebraska, Indiana & Michigan).